Search Results for "Domperidone Sr Bioequivalence"
Original Source: A bioequivalence study of two tamsulosin sustained-release tablets in Indonesian healthy volunteers.
The bioavailability of two 0.4 mg tamsulosin sustained-release film-coated tablet formulations was compared; using generic tablets (Prostam(®)) as test formulation and the originator product as reference formulation. Twenty-four subjects were included in this single-dose, open-label, randomized two-way crossover design following an overnight fasting. A one-week wash-out period was applied. Blood samples were drawn up to 72 h following drug administration. Plasma concentration of tamsulosin was determined...
Matching Channels
None
Matching News
FDA Approving More ANDAs That Use Novel Bioequivalence Methods
OGD officials report on the progress being made in approving generic drugs using more novel and science-based bioequivalence methods than in the past. Officials impart tips on how to submit review-rea...
RedHill bioequivalence trial with RHB-103 meets specified endpoints
RedHill Biopharma has announced positive results from a pivotal bioequivalence trial with RHB-103, an oral thin-film formulation of Rizatriptan for the treatment of acute migraine.
Domperidone Under Scrutiny in Europe Due to Cardiac Risks
The antiemetic, which also can increase lactation in nursing mothers, is used in the United States despite the lack of FDA approval. News Alerts
Generic Bupropion XL Reevaluation Running Behind Schedule
FDA has received data from just one of four bioequivalence studies of 300 mg bupropion extended-release generics it requested by March from sponsors following Impax/Teva’s withdrawal of their generi...
Strong mother-baby bond: Health Canada endorses important safety information regarding Domperidone
Health Canada disapprove the use of Domperidone for mothers. Health Canada states changes to QT interval can lead to serious abnormal heart rhythms which can be harmful to lactation. (PRWEB) June 22,...
Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer
Azaya Therapeutics, Inc. today announced the initiation of a bioequivalence study of ATI-0918 in patients with ovarian cancer.
Bioequivalence Testing Is First Step In China’s Pharma Industry Upgrade – RDPAC
Time is tight for China to complete an ambitious generic bioequivalence testing schedule, and the stakes couldn’t be higher for the industry, a top executive of the leading trade association in Chin...
Type: Review PaperFixed-dose combination (FDC) products are becoming a popular treatment option because of increased patient compliance and convenience, improved clinical effectiveness, and reduced co...
Matching PubMed Articles
BACKGROUND: Domperidone is a useful alternative to metoclopramide for treatment of gastroparesis due to better tolerability. Effectiveness and side-effects from domperidone may be influenced by patien...
BACKGROUND: Accelerated gastric emptying (GE) may lead to reduced satiation, increased food intake and is associated with obesity and type 2 diabetes. Domperidone is a dopamine 2...
HPMA Based Amphiphilic Copolymers Mediate Central Nervous Effects of Domperidone.
In this study we give evidence that domperidone encapsulated into amphiphilic p(HPMA)-co-p(laurylmethacrylate) (LMA) copolymer aggregates is able to cross the blood-brain barrier, since it affected mo...
We have reported that nicotine and the specific α7AChR agonist ameliorate indomethacin-induced intestinal lesions in mice by activating α7 nicotinic acetylcholine receptors (α7nAChR). Dopamine D(2)...
PURPOSE: Limited information from spontaneous reports and results of two case-control studies raised concern about the cardiotoxicity of oral domperidone therapy. This case-control study nested in a r...
